Miravirsen Study in Null Responder to Pegylated Interferon Alpha Plus Ribavirin Subjects With Chronic Hepatitis C

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01727934
Recruitment Status : Unknown
Verified January 2014 by Santaris Pharma A/S.
Recruitment status was:  Active, not recruiting
First Posted : November 16, 2012
Last Update Posted : January 6, 2014
Information provided by (Responsible Party):
Santaris Pharma A/S

No Study Results Posted on for this Study
  Recruitment Status : Unknown
  Estimated Primary Completion Date : January 2014
  Estimated Study Completion Date : April 2014